HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

KP-496

a dual antagonist at the cysteinyl leukotriene receptor 1 and the thromboxane A(2) receptor
Also Known As:
(2-(N-(4-(4-chlorobenzenesulphonylamino) butyl)-N-(3-(4-isopropylthiazol-2-yl)methoxy)benzyl)sulfamoyl)benzoic acid
Networked: 6 relevant articles (3 outcomes, 2 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Suda, Masahiro: 4 articles (10/2010 - 12/2006)
2. Ishimura, Masakazu: 4 articles (10/2010 - 12/2006)
3. Kurokawa, Shigeo: 3 articles (10/2010 - 01/2009)
4. Nakamura, Tsutomu: 2 articles (10/2010 - 01/2009)
5. Okuda, Toshiaki: 2 articles (10/2010 - 01/2009)
6. Hiyama, Yoshiyuki: 2 articles (06/2009 - 12/2006)
7. Kataoka, Sayuri: 2 articles (06/2009 - 12/2006)
8. Maeda, Takashi: 2 articles (06/2009 - 12/2006)
9. Suda, M: 2 articles (06/2008 - 02/2008)
10. Ishimura, M: 2 articles (06/2008 - 02/2008)

Related Diseases

1. Asthma (Bronchial Asthma)
2. Nasal Obstruction
3. Rhinitis
4. Inflammation
5. Airway Obstruction (Choking)

Related Drugs and Biologics

1. sephadex
2. leukotriene D4 receptor (cysteinyl leukotriene receptor)
3. Prostaglandin H2 Thromboxane A2 Receptors
4. Leukotriene D4
5. Thromboxane A2 (A2, Thromboxane)
6. Bleomycin (Blenoxane)
7. Antigens
8. cysteinyl-leukotriene

Related Therapies and Procedures

1. Airway Management